Free Trial

Accenture (ACN) Stock Forecast & Price Target

Accenture logo
$316.36 +2.78 (+0.89%)
Closing price 04/2/2025 03:58 PM Eastern
Extended Trading
$308.59 -7.77 (-2.46%)
As of 04/2/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Accenture - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
7
Buy
16

Based on 23 Wall Street analysts who have issued ratings for Accenture in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 23 analysts, 7 have given a hold rating, 15 have given a buy rating, and 1 has given a strong buy rating for ACN.

Consensus Price Target

$378.23
19.56% Upside
According to the 23 analysts' twelve-month price targets for Accenture, the average price target is $378.23. The highest price target for ACN is $425.00, while the lowest price target for ACN is $295.00. The average price target represents a forecasted upside of 19.56% from the current price of $316.36.
Get the Latest News and Ratings for ACN and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Accenture and its competitors.

Sign Up

ACN Analyst Ratings Over Time

TypeCurrent Forecast
4/3/24 to 4/3/25
1 Month Ago
3/4/24 to 3/4/25
3 Months Ago
1/4/24 to 1/3/25
1 Year Ago
4/4/23 to 4/3/24
Strong Buy
1 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
15 Buy rating(s)
15 Buy rating(s)
14 Buy rating(s)
14 Buy rating(s)
Hold
7 Hold rating(s)
8 Hold rating(s)
8 Hold rating(s)
7 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$378.23$388.96$383.23$387.00
Forecasted Upside19.56% Upside12.47% Upside8.30% Upside16.47% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Remove Ads

ACN Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ACN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Accenture Stock vs. The Competition

TypeAccentureComputer and Technology CompaniesS&P 500
Consensus Rating Score
2.74
2.68
2.54
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside19.56% Upside604.22% Upside17.77% Upside
News Sentiment Rating
Positive News

See Recent ACN News
Positive News
Positive News
Remove Ads
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
3/26/2025BMO Capital Markets
4 of 5 stars
 Boost TargetHold$355.00+13.76%
3/24/2025Barclays
3 of 5 stars
Ramsey El-Assal
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOverweight ➝ Overweight$415.00 ➝ $390.00+27.80%
3/21/2025Royal Bank of Canada
4 of 5 stars
Daniel Perlin
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOutperform ➝ Outperform$399.00 ➝ $392.00+29.36%
3/21/2025UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Kevin Mcveigh
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetBuy ➝ Buy$455.00 ➝ $387.00+28.87%
3/21/2025Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Jonathan Lee
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetBuy ➝ Buy$400.00 ➝ $395.00+33.47%
3/20/2025Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Ramnani
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOverweight ➝ Overweight$396.00 ➝ $364.00+20.98%
3/19/2025Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Dan Dolev
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOutperform ➝ Outperform$428.00 ➝ $398.00+22.76%
3/17/2025Baird R W
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Koning
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
3/17/2025Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
James Faucette
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetEqual Weight ➝ Equal Weight$380.00 ➝ $372.00+16.88%
3/17/2025Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
David Koning
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Outperform$390.00 ➝ $390.00+22.53%
2/26/2025Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
David Grossman
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetBuy ➝ Buy$390.00 ➝ $380.00+4.62%
1/21/2025Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Surinder Thind
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetHold ➝ Hold$385.00 ➝ $355.00+0.22%
1/8/2025Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Peller
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradePeer Perform ➝ Outperform$425.00+19.15%
12/16/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$370.00 ➝ $396.00+10.47%
12/6/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Schneider
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$370.00 ➝ $420.00+17.28%
10/30/2024BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Slowinski
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Neutral$375.00+4.90%
9/30/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
B. Bergin
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$321.00 ➝ $400.00+14.38%
9/27/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$365.00 ➝ $388.00+9.05%
9/27/2024Susquehanna
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$350.00 ➝ $360.00+1.18%
9/20/2024Piper Sandler Companies
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingNeutral$329.00-1.86%
9/17/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$350.00 ➝ $405.00+19.35%
6/12/2024Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$400.00 ➝ $350.00+19.58%
5/15/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$409.00 ➝ $295.00-3.86%
3/19/2024Redburn Atlantic
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$410.00 ➝ $445.00+19.41%
7/7/2023Societe Generale
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$314.00 ➝ $373.00+21.10%
4/5/2023Edward Jones
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 01:21 AM ET.


Should I Buy Accenture Stock? ACN Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, March 31, 2025. Please send any questions or comments about these Accenture pros and cons to contact@marketbeat.com.

Accenture
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Accenture:

  • Accenture has received multiple upgrades from analysts, including a recent upgrade to an "outperform" rating with a target price of $425.00, indicating strong potential for growth.
  • The company has a consensus price target of $378.23, suggesting that analysts expect the stock to rise from its current price of $304.32, providing a significant upside for investors.
  • Accenture's market capitalization stands at $190.61 billion, reflecting its strong position in the market and stability as a large-cap stock, which is often considered less risky.
  • Recent insider transactions show that executives are actively managing their holdings, with significant sales indicating confidence in the company's future performance.
  • Accenture's strong financial ratios, including a low debt-to-equity ratio of 0.17, suggest a solid balance sheet and lower financial risk, making it an attractive option for conservative investors.

Accenture
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Accenture for these reasons:

  • The stock has recently experienced a decline of 1.4%, which may indicate short-term volatility and potential challenges in maintaining its price level.
  • Insider sales, while sometimes viewed positively, can also raise concerns about the executives' confidence in the company's near-term performance, especially with significant sales by the CEO.
  • With a price-to-earnings ratio of 25.53, the stock may be considered overvalued compared to its earnings, which could deter value-focused investors.
  • The company's quick ratio of 1.47, while indicating adequate liquidity, may not be sufficient in times of economic downturns, raising concerns about its ability to cover short-term liabilities.
  • Accenture operates in a highly competitive industry, and any shifts in market dynamics or technological advancements could impact its market share and profitability.

ACN Forecast - Frequently Asked Questions

According to the research reports of 23 Wall Street equities research analysts, the average twelve-month stock price forecast for Accenture is $378.23, with a high forecast of $425.00 and a low forecast of $295.00.

23 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Accenture in the last year. There are currently 7 hold ratings, 15 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" ACN shares.

According to analysts, Accenture's stock has a predicted upside of 19.56% based on their 12-month stock forecasts.

Over the previous 90 days, Accenture's stock had 3 upgrades by analysts.

Analysts like Accenture more than other "computer and technology" companies. The consensus rating score for Accenture is 2.74 while the average consensus rating score for "computer and technology" companies is 2.68. Learn more on how ACN compares to other companies.


This page (NYSE:ACN) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners